COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ:OSIR), a leading stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic, and cardiovascular areas, announced today the addition Dr. Jeffry Lawrence, M.D. as Executive Medical Director and Dr. Jesus Soriano M.D., Ph.D. as Senior Director of Business Development.
